Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation

[1]  Curtis R. Heberle,et al.  Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  N. Shaheen,et al.  Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett’s Esophagus With Radiofrequency Ablation , 2017, The American Journal of Gastroenterology.

[3]  A. Thrift.  Determination of risk for Barrett's esophagus and esophageal adenocarcinoma , 2016, Current opinion in gastroenterology.

[4]  Siddharth Singh,et al.  Risk of recurrence of Barrett's esophagus after successful endoscopic therapy. , 2016, Gastrointestinal endoscopy.

[5]  H. El‐Serag,et al.  Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  A. Thrift.  Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  H. El‐Serag,et al.  Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. , 2015, Gastroenterology.

[8]  H. Wolfsen,et al.  Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus. , 2015, Gastroenterology.

[9]  H. El‐Serag,et al.  Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus , 2014, Gut.

[10]  H. El‐Serag,et al.  The Incidence of Esophageal Adenocarcinoma in a National Veterans Cohort With Barrett’s Esophagus , 2014, The American Journal of Gastroenterology.

[11]  D. Graham,et al.  Risk Factors for Barrett’s Esophagus Compared Between African Americans and Non-Hispanic Whites , 2014, The American Journal of Gastroenterology.

[12]  B. Overholt,et al.  Durability and predictors of successful radiofrequency ablation for Barrett's esophagus. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  G. Ginsberg,et al.  Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. , 2013, Gastroenterology.

[14]  J. Akiyama,et al.  Mo1913 Erosive Esophagitis Is a Major Predictor for Recurrence of Barrett's Esophagus After Successful Radiofrequency Ablation , 2013 .

[15]  A. Thrift,et al.  The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  C. Lightdale,et al.  Detection of Intestinal Metaplasia After Successful Eradication of Barrett’s Esophagus with Radiofrequency Ablation , 2011, Digestive Diseases and Sciences.

[17]  Peter J. Richardson,et al.  Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. , 2010, Gastroenterology.

[18]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[19]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.